Could this pill protect Kids' brains from sickle cell damage?
NCT ID NCT05018728
Summary
This study tested whether the sickle cell disease drug voxelotor improves blood flow and oxygen delivery to the brain in children. Researchers gave 22 children and young adults (ages 4-30) daily voxelotor for 12 weeks and used light-based scans to measure brain oxygen levels. The goal was to see if increasing hemoglobin with this approved drug reduces strain on the brain's blood vessels, potentially lowering stroke risk.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL ANEMIA IN CHILDREN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aflac Sickle Cell Comprehensive Clinics at Children's Healthcare of Atlanta, Scottish Rite
Atlanta, Georgia, 30342, United States
-
Children's Healthcare of Atlanta
Atlanta, Georgia, 30322, United States
Conditions
Explore the condition pages connected to this study.